Summary
Creatine (Cr) and cyclocreatine (cyCr) have been shown to inhibit the growth of a variety of human and murine tumours. The purpose of this study was to evaluate the anti-tumour effect of these molecules in relation to drug accumulation, energy metabolism, tumour water accumulation and toxicity. Nude mice carrying a human colon adenocarcinoma (LS174T) with a creatine kinase (CK) activity of 2.12 units mg–1 protein were fed Cr (2.5% or 5%) or cyCr (0.025%, 0.1% or 0.5%) for 2 weeks and compared with controls fed standard diet. Cr concentrations of 2.5% and 5% significantly inhibited tumour growth, as did 0.1% and 0.5% cyCr. In vivo 31P magnetic resonance spectroscopy (MRS) after 2 weeks of treatment showed an increase in [phosphocreatine (PCr)+phosphocyclocreatine (PcyCr)]/nucleoside triphosphate (NTP) with increasing concentrations of dietary Cr and cyCr, without changes in absolute NTP contents. The antiproliferative effect of the substrates of CK was not related to energy deficiency but was associated with acidosis. Intratumoral substrate concentrations (measured by 1H-MRS) of 4.8 μmol g–1 wet weight Cr (mice fed 2.5% Cr) and 6.2 μmol g–1 cyCr (mice fed 0.1% cyCr) induced a similar decrease in growth rate, indicating that both substrates were equally potent in tumour growth inhibition. The best correlant of growth inhibition was the total Cr or (cyCr+Cr) concentrations in the tissue. In vivo, these agents did not induce excessive water accumulation and had no systemic effects on the mice (weight loss, hypoglycaemia) that may have caused growth inhibition.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Askenasy, N. & Koretsky, A. P. (1997). Differential effects of creatine kinase isoenzymes and substrates on regeneration in livers of transgenic mice. Am J Physiol 273: C741–C746.
Bartholomew, L. G. & Schutt, A. J. (1971). Systemic syndromes associated with neoplastic disease including cancer of the colon. Cancer 28: 170–174.
Bereznitsky, S., Lobstein, O. E., Ko, S. T. & Weinstock, A. (1982). Alterations of creatine kinase isoenzymes in colon washings from patients with colonic and rectal diseases. Cancer 50: 1177–1180.
Bergnes, G., Yuan, W., Khandekar, V. S., O’Keefe, M. M., Martin, K. J., Teicher, B. A. & Kaddurah-Daouk, R. (1996). Creatine and phosphocreatine analogs: anticancer activity and enzymatic analysis. Oncol Res 8: 121–130.
Carney, D. N., Zweig, M. H., Ihde, D. C., Cohen, M. H., Maduch, R. W. & Gazdar, A. F. (1984). Elevated serum creatine kinase BB levels in patients with small cell lung cancer. Cancer Res 44: 5399–5403.
DeLuca, M., Hall, N., Rice, R. & Kaplan, N. O. (1981). Creatine kinase isozymes in human tumours. Biochem Biophys Res Commun 99: 189–195.
Eskey, C. J., Koretsky, A. P., Domach, M. M. & Jain, R. K. (1993). Role of oxygen vs glucose in energy metabolism in a mammary carcinoma perfused ex vivo: direct measurement by 31P NMR. Proc Natl Acad Sci USA 90: 2646–2650.
Giovanella, B. C., Shepard, R. C., Stehlin, J. S., Venditti, J. M. & Abbott, B. J. (1982). Calorie restriction: effect on growth of human tumours heterotransplanted in nude mice. J Natl Cancer Inst 68: 249–257.
Griffith, J. R. (1991). Are cancer cells acidic?. Br J Cancer 64: 425–427.
Guimbal, C. & Kilimann, M. W. (1993). A Na+-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression. J Biol Chem 268: 8418–8421.
Hall, N. & DeLuca, M. (1976). Electrophoretic separation and quantitation of creatine kinase isozymes. Anal Biochem 76: 561–567.
Kaddurah-Daouk, R., Lillie, J. W., Daouk, G. H., Green, M. R., Kingston, R. & Schimmel, P. (1990). Induction of a cellular enzyme for energy metabolism by transforming domains of adenovirus E1a. Mol Cell Biol 10: 1476–1483.
Kristensen, C. A., Kristjansen, P. E. G., Brünner, N., Quistorff, B. & Spang-Thomsen, M. (1995). Growth inhibition in response to estrogen withdrawal and tamoxifen therapy of human breast cancer xenografts evaluated by in vivo 31P magnetic resonance spectroscopy, creatine kinase activity, and apoptotic index. Cancer Res 55: 4146–4150.
Lillie, J. W., O’Keefe, M., Valinski, H., Hamlin, H. A., Varban, M. L. & Kaddurah-Daouk, R. (1993). Cyclocreatine (1-carboxymethyl-2-iminoimidazolidine) inhibits growth of a broad spectrum of cancer cells derived from solid tumours. Cancer Res 53: 3172–3178.
LoPresti, P. & Cohn, M. (1989). Direct determination of creatine kinase equilibrium constants with creatine or cyclocreatine substrate. Biochim Biophys Acta 998: 317–320.
Martin, K. J., Chen, S-F, Clark, G. M., Degen, D., Wajima, M., Von Hoff, D. D. & Kaddurah-Daouk, R. (1994a). Evaluation of creatine analogues as a new class of anticancer agents using freshly explanted human tumour cells. J Natl Cancer Inst 86: 608–613.
Martin, K. J., Winslow, E. R. & Kaddurah-Daouk, R. (1994b). Cell cycle studies of cyclocreatine, a new anticancer agent. Cancer Res 54: 5160–5165.
Martin, K. J., Vassallo, C. D., Teicher, B. A. & Kaddurah-Daouk, R. (1995). Microtubule stabilization and potentiation of taxol by the creatine analog cyclocreatine. Anti-Cancer Drugs 6: 419–426.
McAuliffe, J. J., Perry, S. B., Brooks, E. E. & Ingwall, J. S. (1989). The kinetics of the creatine kinase reaction in neonatal rabbit heart: does the rate equation accurately describe the kinetics observed in the isolated perfused heart?. Prog Clin Biol Res 315: 581–592.
Miller, E. E., Evans, A. E. & Cohn, M. (1993). Inhibition of rate of tumour growth by creatine and cyclocreatine. Proc Natl Acad Sci USA 90: 3304–3308.
Neri, B., Bartalucci, S., Romano, S. & Cipriani, A. (1985). Evaluation of creatine kinase isoenzyme BB as a marker of neoplastic growth in Yoshida ascites hepatoma of the rat. Anticancer Res 5: 533–536.
Perry, S. B., McAuliffe, J. J., Balschi, J. A., Hickey, P. R. & Ingwall, J. S. (1988). Velocity of the creatine kinase reaction in the neonatal rabbit heart: role of mitochondrial creatine kinase. Biochemistry 27: 2165–2172.
Schiffenbauer, Y. S., Tempel, C., Abramovitch, R., Meir, G. & Neeman, M. (1995). Cyclocreatine accumulation leads to cellular swelling in C6 glioma multicellular spheroids: diffusion and one dimensional chemical shift nuclear magnetic resonance microscopy. Cancer Res 55: 153–158.
Schiffenbauer, Y. S., Meir, G., Cohn, M. & Neeman, M. (1996). Cyclocreatine transport and cytotoxicity in rat glioma and human ovarian carcinoma cells: 31P-NMR spectroscopy. Am J Physiol 270: C160–C169.
Schimmel, L., Khandekar, V. S., Martin, K. J., Riera, T., Honan, C., Shaw, D. G. & Kaddurah-Daouk, R. (1996). The synthetic phosphagen cyclocreatine phosphate inhibits the growth of a broad spectrum of solid tumours. Anticancer Res 16: 375–380.
Shatton, J. B., Morris, H. P. & Weinhouse, S. (1979). Creatine kinase activity and isozyme composition in normal tissues and neoplasms of rats and mice. Cancer Res 39: 492–501.
Sora, I., Richman, J., Santoro, G., Wei, H., Wang, Y., Vanderah, T., Horvath, R., Nguyen, M., Waite, S., Roeske, W. R. & Yamamura, H. I. (1994). The cloning and expression of a human creatine transporter. Biochem Biophys Res Commun 204: 419–427.
Spang-Thomsen, M., Nielsen, A. & Visfeldt, J. (1980). Growth curves of three human malignant tumours transplanted to nude mice. Exp Cell Biol 48: 138–154.
Teicher, B. A., Menon, K., Northey, D., Liu, J., Kufe, D. W. & Kaddurah-Daouk, R. (1995). Cyclocreatine in cancer chemotherapy. Cancer Chemother Pharmacol 35: 411–416.
Walliman, T., Wyss, M., Brdiczka, D., Nicolay, K. & Eppenberger, H. M. (1992). Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the “phosphocreatine circuit” for cellular energy homeostasis. Biochem J 281: 21–40.
Zhao, J., Schmieg, F. I., Simmons, D. T. & Malloy, G. R. (1994). Mouse p53 represses the rat brain creatine kinase gene but activates the rat muscle creatine kinase gene. Mol Cell Biol 14: 8483–8492.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Kristensen, C., Askenasy, N., Jain, R. et al. Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies. Br J Cancer 79, 278–285 (1999). https://doi.org/10.1038/sj.bjc.6690045
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6690045
Keywords
This article is cited by
-
Creatine metabolism: energy homeostasis, immunity and cancer biology
Nature Reviews Endocrinology (2020)
-
Important roles of dietary taurine, creatine, carnosine, anserine and 4-hydroxyproline in human nutrition and health
Amino Acids (2020)
-
Exploratory studies of the potential anti-cancer effects of creatine
Amino Acids (2016)
-
Creatine supplementation with methylglyoxal: a potent therapy for cancer in experimental models
Amino Acids (2016)
-
An overview of amines as nutritional supplements to counteract cancer cachexia
Journal of Cachexia, Sarcopenia and Muscle (2014)